Skip to content
10-Q

Quarterly Report

JINZANGHUANG TIBET PHARMACEUTICALS, INC.

0001096906-12-000354

← back to feed
Filed
Feb 16, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Feb 16, 2012 40.67M sh
Shares Diluted Q2 2012 · Dec 31, 2011 40.67M sh
Shares Diluted Q2 2012 · Dec 31, 2011 40.67M sh
Shares Diluted Q2 2012 · Dec 31, 2010 40.67M sh
Shares Diluted Q2 2012 · Dec 31, 2010 40.67M sh
Cash And Equivalents Q2 2012 · Dec 31, 2011 $5.25M
Cash And Equivalents Q2 2012 · Jun 30, 2011 $2.18M
Cash And Equivalents Q2 2012 · Dec 31, 2010 $246.79K
Cash And Equivalents Q2 2012 · Jun 30, 2010 $42.18K
Stockholders Equity Q2 2012 · Dec 31, 2011 $6.23M
Stockholders Equity Q2 2012 · Jun 30, 2011 $3.05M
Total Liabilities Q2 2012 · Dec 31, 2011 $561.28K
Total Liabilities Q2 2012 · Jun 30, 2011 $562.42K
Current Assets Q2 2012 · Dec 31, 2011 $6.52M
Current Assets Q2 2012 · Jun 30, 2011 $3.18M
Total Assets Q2 2012 · Dec 31, 2011 $7.12M
Total Assets Q2 2012 · Jun 30, 2011 $3.77M
Operating Cash Flow Q2 2012 · Dec 31, 2010 $201.26K
Sga Expense Q2 2012 · Dec 31, 2010 $64.86K
Sga Expense Q2 2012 · Dec 31, 2010 $98.74K
Net Income Q2 2012 · Dec 31, 2010 $296.32K
Net Income Q2 2012 · Dec 31, 2010 $273.31K
Operating Income Q2 2012 · Dec 31, 2010 $419.31K
Operating Income Q2 2012 · Dec 31, 2010 $387.8K
Gross Profit Q2 2012 · Dec 31, 2010 $484.17K
Gross Profit Q2 2012 · Dec 31, 2010 $486.54K
Cost Of Revenue Q2 2012 · Dec 31, 2010 $68.87K
Cost Of Revenue Q2 2012 · Dec 31, 2010 $93.17K
Revenue Q2 2012 · Dec 31, 2010 $553.04K
Revenue Q2 2012 · Dec 31, 2010 $579.71K